Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

DCTH

Delcath Systems (DCTH)

Delcath Systems Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DCTH
DateTimeSourceHeadlineSymbolCompany
26/09/202420:11Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DCTHDelcath Systems Inc
26/09/202420:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DCTHDelcath Systems Inc
26/09/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DCTHDelcath Systems Inc
26/09/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DCTHDelcath Systems Inc
21/09/202406:01Business WireDelcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DCTHDelcath Systems Inc
19/09/202407:10Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:DCTHDelcath Systems Inc
19/09/202407:07Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:DCTHDelcath Systems Inc
16/09/202422:30Business WireDelcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KITâ„¢ in Metastatic Uveal Melanoma SubgroupsNASDAQ:DCTHDelcath Systems Inc
29/08/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
29/08/202406:01Business WireDelcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:DCTHDelcath Systems Inc
29/08/202406:01Business WireDelcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma PatientsNASDAQ:DCTHDelcath Systems Inc
28/08/202422:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
27/08/202422:30Business WireDelcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma PatientsNASDAQ:DCTHDelcath Systems Inc
27/08/202406:01Business WireDelcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver TumorsNASDAQ:DCTHDelcath Systems Inc
20/08/202422:30Business WireDelcath Systems Announces Poster Presentation at the 2024 ESMO CongressNASDAQ:DCTHDelcath Systems Inc
13/08/202406:01Business WireDelcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DCTHDelcath Systems Inc
06/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DCTHDelcath Systems Inc
06/08/202406:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DCTHDelcath Systems Inc
06/08/202406:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
06/08/202406:01Business WireDelcath Systems Reports Second Quarter 2024 Results and Business HighlightsNASDAQ:DCTHDelcath Systems Inc
05/08/202422:30Business WireDelcath Systems Announces CMS Approval for NTAP for HEPZATO KITâ„¢NASDAQ:DCTHDelcath Systems Inc
31/07/202406:01Business WireDelcath Systems to Participate in Upcoming Investor ConferencesNASDAQ:DCTHDelcath Systems Inc
23/07/202406:01Business WireDelcath Systems to Host Second Quarter 2024 Earnings CallNASDAQ:DCTHDelcath Systems Inc
20/07/202406:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
10/07/202401:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DCTHDelcath Systems Inc
09/07/202423:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
30/05/202406:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
29/05/202406:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
29/05/202406:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
29/05/202406:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
 Showing the most relevant articles for your search:NASDAQ:DCTH